Mersana Therapeutics Announces Appointment of Allene Diaz to Board of Directors
CAMBRIDGE, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering...
News
Sio Gene Therapies to Participate in Upcoming Investor & Scientific Conferences
NEW YORK and RESEARCH TRIANGLE PARK, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a...
Vaccine Passports: Balancing the benefits against the risks
Dr Adrian Hyzler, Chief Medical Officer at Healix International/HX Global provides his perspective on the current debate about Vaccine Passports...
aTyr Pharma Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery...
Kane Biotech to Participate in Maxim Group LLC Inaugural Emerging Growth Conference
WINNIPEG, Manitoba, March 11, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today...
CymaBay Therapeutics to Present at the 2021 NASH-TAG Conference
NEWARK, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003
Trial to be Conducted by Pontificia Universidad Católica de Chile in Q2 2021VANCOUVER, March 11, 2021 (GLOBE NEWSWIRE) -- BetterLife...
Alimera Sciences to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
ATLANTA, March 11, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the...
Vaccinex to Present at the Oppenheimer 31st Annual Healthcare Conference
ROCHESTER, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach...
I-Mab To Present Differentiated Mechanism of Action and Preclinical Data for Anti-CD73 Antibody Uliledlimab at 2021 American Association for Cancer Research Annual Meeting
SHANGHAI, China and GAITHERSBURG, Md., March 11, 2021 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (NASDAQ: IMAB), a clinical stage biopharmaceutical...
Clubhouse Media Group Influencer and Pro Racing Star Lindsay Brewer Scores Top-Ten Finish in Triumphant Return to the Track
LOS ANGELES, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS: CMGR) (“Clubhouse Media” or...
Maple Leaf Green World Inc. Announces Its New CBG Cigarette Brand “Phoenix Crave”
CALGARY, Alberta, March 11, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”) (NEO: MGW,...
Algernon Pharmaceuticals Provides Update on Timing of Topline Results for Phase 2b/3 COVID-19 Trial of Ifenprodil
VANCOUVER, British Columbia, March 11, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Vivos Therapeutics to Participate at the Q1 Virtual Investor Summit
Vivos management to present at 1:30 pm Eastern Time on March 23, 2021 HIGHLANDS RANCH, Colo., March 11, 2021 (GLOBE...
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2020
GAITHERSBURG, Md., March 11, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the...
Miravo Healthcare to present at the Q1 Virtual Investor Summit
MISSISSAUGA, Ontario, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare™ today...
Acerus Reports Fourth Quarter and Full Year 2020 Financial Results
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported...
The Balancing Act® on Lifetime to Feature ENPP1 Deficiency
Educational Episode to Highlight Symptoms of ENPP1 Deficiency and the Importance of Early DiagnosisBOSTON, March 11, 2021 (GLOBE NEWSWIRE) -- Inozyme...
Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview
- Initiation of Phase 1 Trial of TARA-002 in Patients with Non-Muscle Invasive Bladder Cancer on Track to Commence by...
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
New Drug Application (“NDA”) submitted to the U.S. Food and Drug Administration (“FDA”) for BXCL501 for the acute treatment of schizophrenia...